Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 8 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

38%

3 trials in Phase 3/4

Results Transparency

0 of 7 completed trials have results

Key Signals

Enrollment Performance

Analytics

Phase 4

3(42.9%)

N/A

2(28.6%)

Phase 2

1(14.3%)

Phase 1

1(14.3%)

7Total

Phase 4(3)

N/A(2)

Phase 2(1)

Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (8)

Showing 8 of 8 trials

NCT07458828Not ApplicableCompleted

Evaluate the Efficacy and Safety of Hydrolyzed Keratin Peptide Powder on Hair Health

Role: lead

NCT04871321Completed

Biomarker Discovery in Patients With Advanced Biliary Tract Cancer

Role: collaborator

NCT01759836Phase 2Completed

Impact of Adjuvant Statin Therapy in Patients Who Underwent Radical Prostatectomy for Locally Advanced Prostate Cancer

Role: collaborator

NCT03542721Phase 4Unknown

Effect of DA-5515 (Circulan® Soft Cap.) in Patients With Chronic Fatigue Symptoms Due to Impaired Blood Circulation

Role: lead

NCT03117153Not ApplicableCompleted

Effect of a Liquid Toothpaste on Periodontal Disease

Role: lead

NCT02100917Phase 1Completed

Bioequivalence Study Evaluating the Pharmacokinetics of DMB-3111 and Trastuzumab in Healthy Japanese Male Adults

Role: collaborator

NCT02060786Phase 4Completed

Point-of-Care Measurements of Platelet Inhibition After Clopidogrel Loading in Patients With Acute Coronary Syndrome: Comparison of Generic Clopidogrel Bisulfate (Plavitor®) With Original Clopidogrel Bisulfate (Plavix®)

Role: collaborator

NCT01285544Phase 4Completed

The Efficacy and Tolerability of Two Formulations of Atorvastatin In Korean Adult With Hypercholesterolemia

Role: collaborator

All 8 trials loaded